fashion -WSS

fashion

author：fashion 2025-08-31 00:04:01 - browse：66646

Adobe

The Food and Drug Administration has cleared Otsuka Pharmaceutical’s digital treatment for major depressive disorder, offering a new option for millions of people who struggle with the stubborn mental health condition.

Called Rejoyn, the smartphone-based treatment for major depressive disorder symptoms was developed with digital health company Click Therapeutics, and it is intended for use by prescription alongside antidepressants. The six-week program delivers a novel “cognitive-emotional training” technique, in which people are asked to identify and recall faces showing different emotions. Researchers hypothesize that the technique targets the brain’s dorsolateral prefrontal cortex and the amygdala and may “enhance cognitive control over emotional information processing.” Patients also receive cognitive behavioral therapy.

Rejoyn has been in development since 2018, and Otsuka is the first drug company to receive FDA clearance for a digital treatment for a mental health condition. But that landmark comes amid many questions about whether such digital therapeutics deliver their advertised results — and whether they can gain traction with clinicians, insurers, and patients. Prescription digital therapeutics have yet to see a blockbuster success, and several companies have gone out of business trying to create one.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Hospitals warn Medicare's drug payment fix is ‘unlawful’

WSS

Diversifying clinical trials isn't enough to close racial gaps: study

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Medtronic CEO on promising devices for diabetes, hypertension

Second House panel advances two

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

hotspot

fashion

knowledge

Hollywood unions extend contract negotiations for actors

Physician subsidies by hospitals soar in wake of No Surprises Act

Peter Hotez and the public health issue of online harassment

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Medical records are filled with copy

Criminal prosecution for violating HIPAA: an emerging threat

BioMarin wins approval for gene therapy to treat hemophilia A

Telehealth options flood the market as retailers push virtual care

FDA approval of Sarepta Duchenne genetic therapy gives me hope

When prostate cancer spreads, where it goes matters

knowledge

Readout Newsletter: What happened with Sarepta's Duchenne data

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Telehealth options flood the market as retailers push virtual care

Second House panel advances two

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Readout LOUD podcast: Live from STAT Breakthrough Summit West

hotspot

entertainment

entertainment

entertainment